1. Argyrin F Treatment‐Induced Vulnerabilities Lead to a Novel Combination Therapy in Experimental Glioma. Issue 9 (19th June 2021) Authors: Walter, Bianca; Canjuga, Denis; Yüz, Simge G.; Ghosh, Michael; Bozko, Przemyslaw; Przystal, Justyna M.; Govindarajan, Parameswari; Anderle, Nicole; Keller, Anna‐Lena; Tatagiba, Marcos; Schenke‐Layland, Katja; Rammensee, Hans‐Georg; Stevanovic, Stefan; Malek, Nisar P.; Schmees, Christian; Tabataba... Journal: Advanced therapeutics Issue: Volume 4:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXPERT INSIGHT Advancement of precision oncology by integration of highly sensitive protein profiling technologies and patient-derived cell models for functional efficacy testing. Issue 4 (2021) Authors: Pawlak, Michael; Templin, Markus; Schmees, Christian Journal: Immuno-oncology insights Issue: Volume 2:Issue 4(2021) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EXTH-48. NOVEL COMBINATION THERAPY IN PRECLINICAL GLIOMA MODELS USING THE CELL CYCLE STABILIZING COMPOUND ARGYRIN F AND CHECKPOINT INHIBITION. (12th November 2021) Authors: Walter, Bianca; Canjuga, Denis; Yuez, Simge G; Ghosh, Michael; Bozko, Przemyslaw; Przystal, Justyna; Govindarajan, Parameswari; Anderle, Nicole; Keller, Anna-Lena; Tatagiba, Marcos; Schenke-Layland, Katja; Rammensee, Hans-Georg; Stevanovic, Stefan; Malek, Nisar P; Schmees, Christian; Tabatabai, G... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FOREWORD Enhancing preclinical predictivity: what is going wrong between preclinical in vitro/in vivo and clinical in vivo settings?. Issue 4 (2021) Authors: Schmees, Christian Journal: Immuno-oncology insights Issue: Volume 2:Issue 4(2021) Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HepaChip-MP – a twenty-four chamber microplate for a continuously perfused liver coculture model. Issue 16 (14th July 2020) Authors: Busche, Marius; Tomilova, Olena; Schütte, Julia; Werner, Simon; Beer, Meike; Groll, Nicola; Hagmeyer, Britta; Pawlak, Michael; Jones, Peter D.; Schmees, Christian; Becker, Holger; Schnabel, Juliane; Gall, Karsten; Hemmler, Roland; Matz-Soja, Madlen; Damm, Georg; Beuck, Simon; Klaassen, Tobias; Mo... Journal: Lab on a chip Issue: Volume 20:Issue 16(2020) Page Start: 2911 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma. Issue 6 (8th June 2022) Authors: Reustle, Anna; Menig, Lena‐Sophie; Leuthold, Patrick; Hofmann, Ute; Stühler, Viktoria; Schmees, Christian; Becker, Michael; Haag, Mathias; Klumpp, Verena; Winter, Stefan; Büttner, Florian A.; Rausch, Steffen; Hennenlotter, Jörg; Fend, Falko; Scharpf, Marcus; Stenzl, Arnulf; Bedke, Jens; Schwab, M... Journal: Clinical and translational medicine Issue: Volume 12:Issue 6(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. TAMI-34. TARGETING CSF1R AND PD1 IN EXPERIMENTAL GLIOMA. (12th November 2021) Authors: Becker, Hannes; Przystal, Justyna M; Canjuga, Denis; Tsiami, Foteini; Anderle, Nicole; Keller, Anna-Lena; Pohl, Anja; Ries, Carola H; Schmittnaegel, Martina; Korinetska, Nataliya; Koch, Marilin; Schittenhelm, Jens; Tatagiba, Marcos; Schmees, Christian; Beck, Susanne C; Tabatabai, Ghazaleh Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗